Table III.

Treatment characteristics of patients (n=36)

Variables	n (%)
Median follow up (95% CI) (months)	12.2 (7.1-17)†
Progression	21 (55.26)
Interval from the last chemotherapy (days)	159 (1-1211)†
ORR (%)	19 (50)
Dose modification: Pazopanib (200 mg)	2 (5.6)
VP-16 (10 days)	6 (16.6)
Treatment interruption	7 (19.4)
Progression-free survival (95% CI) (months)	8.2 (5.03-10.33)†
OS (95% CI) (months)	38 (25.6-NR)

^†Values in parentheses are range. ORR, overall response rate; CI, confidence interval; OS, overall survival; NR, not reached